Banco Santander, S.A. Organon & Co. Transaction History

Banco Santander, S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$31.66 - $38.9 $253 - $311	-8 Reduced 0.06%	14,129 $477,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $83,189 - $107,531	-2,732 Reduced 16.2%	14,137 $494,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $208,430 - $269,935	-7,270 Reduced 30.12%	16,869 $514,000
Q3 2021 Nov 08, 2021	BUY	$28.63 - $35.64 $14,429 - $17,962	504 Added 2.13%	24,139 $791,000
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $672,415 - $898,130	23,635 New	23,635 $715,000

786

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.04B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Santander, S.A. with notifications on news.